Fitness technology spans wearables, activity trackers, connected equipment, apps and feedback programs. The statistics below distinguish U.S. survey estimates, company accounting figures and study-specific trial outcomes across clearly stated periods and populations.
Key Fitness Technology Statistics
The most broadly useful figures include:
- In 2020, 30.2% of U.S. adults reported wearable-device use for health or activity tracking in the preceding 12 months.
- In 2022, 36.7% of U.S. adults reported wearable-device use.
- In 2024, 41.1% of U.S. adults reported wearable-device use.
- Among U.S. adults with cardiovascular disease or major cardiovascular risk factors, wearable use rose from 27.3% in 2020 to 38.4% in 2024.
- In 2024, 45.6% of U.S. wearable users reported daily use during the preceding month.
- In 2024, 19.2% of U.S. wearable users reported sharing wearable or smartphone health information with clinicians in the prior 12 months.
- In 2024, 73.4% of U.S. wearable users were willing to share data with clinicians, although willingness was not the same as actual sharing.
- In fiscal 2024, Peloton subscription revenue was $1,708.7 million, compared with $991.7 million in Connected Fitness Products revenue.
- In fiscal 2024, Peloton total revenue was $2,700.5 million, representing the company’s consolidated business rather than the whole fitness-technology market.
- In a six-week Fitbit trial of overweight and obese adults, SMS prompts plus Fitbit increased steps by 1,266 per day after one week.
- In the same trial, SMS prompts plus Fitbit increased moderate-to-vigorous physical activity by 17.8 minutes per week after one week.
- In a 12-month wearable-ring study, the intervention group increased from 7,446 to 9,626 mean steps per day by month 3.
- At month 12 of that wearable-ring study, long-term guided feedback averaged 11,920 steps per day versus 9,527 in controls.
- In a 12-week consumer wearable trial among sedentary adults, sedentary behavior fell by 81 minutes per day versus control.
- The same 12-week intervention increased steps by 3,117 per day versus control.
- The 12-week intervention reduced body-fat mass by 1.67 kilograms versus control.
- In the Step4Life pilot among hemodialysis patients, structured feedback produced a 920-step daily increase at 12 weeks.
- In a pedometer-based web intervention, 30% of the intervention arm met 10,000 steps per day at the first follow-up, compared with 11% in control.
Contents
- Key Fitness Technology Statistics
- Fitness Technology Adoption and Wearable Use
- Fitness Technology Engagement, Data Sharing and Digital Readiness
- Connected-Fitness Revenue and Business Trends
- Fitness Technology Trials: Steps and Physical Activity
- Fitness Technology Trials: Sedentary Time and Cardiometabolic Outcomes
- Fitness App and Wearable Adherence Over Time
Fitness Technology Adoption and Wearable Use
The national adoption figures come from weighted HINTS estimates for community-dwelling U.S. adults. “Use” means reported wearable use for health or activity tracking in the preceding 12 months, so it is not the same measure as daily engagement or ownership.
| Survey year | Wearable use among U.S. adults |
|---|---|
| 2020 | 30.2% |
| 2022 | 36.7% |
| 2024 | 41.1% |
Source: Wearable Devices and Data Sharing in the US. These are weighted HINTS estimates.
Among adults with cardiovascular disease or major cardiovascular risk factors, wearable use rose from 27.3% in 2020 to 38.4% in 2024. The risk-factor subgroup included hypertension, diabetes, obesity or current smoking, and the figures are not prevalence estimates for every U.S. adult.
The adjusted odds of wearable use increased 30% per two-year survey interval from 2020 to 2024, with an adjusted odds ratio of 1.30 and a 95% confidence interval of 1.19–1.41. This is an adjusted association, not evidence that time itself caused adoption.
In the pooled 2020–2024 HINTS analysis, the weighted mean age of wearable users was 48.7 years, with a standard deviation of 18.1 years. In 2024, women represented 55.3% of wearable users, while 62.3% had cardiovascular disease or a major cardiovascular risk factor; the latter is a characteristic among users, not a population prevalence estimate.
Fitness Technology Engagement, Data Sharing and Digital Readiness
Adoption does not guarantee sustained use or clinical integration. The HINTS measures below separate daily use, willingness to share and reported sharing with clinicians.
| Measure among U.S. wearable users | 2020 | 2022 | 2024 |
|---|---|---|---|
| Daily use | 50.5% | 41.0% | 45.6% |
| Actual sharing with clinicians | 14.2% | 19.0% | 19.2% |
| Willingness to share with clinicians | 81.3% | — | 73.4% |
Source: Wearable Devices and Data Sharing in the US. Daily use means every day in the preceding month; actual sharing refers to wearable or smartphone health information reported shared within the prior 12 months.
Willingness to share fell from 81.3% in 2020 to 73.4% in 2024, while actual reported sharing rose from 14.2% to 19.2% over the same endpoints. Willingness and actual behavior should therefore be read as separate indicators rather than interchangeable measures.
Each two-year interval was associated with 24% lower adjusted odds of willingness to share wearable data, with an adjusted odds ratio of 0.76 and a 95% confidence interval of 0.64–0.90. The adjusted association does not establish why willingness declined.
Digital readiness was associated with use in 2024. A one-point increase in the digital-literacy index corresponded to adjusted odds of 1.53 for wearable use, while a one-point increase in the internet-access index corresponded to adjusted odds of 1.50; these are index-based adjusted associations.
Among wearable users, a one-point increase in digital literacy was associated with adjusted odds of 1.45 for daily use and 1.61 for willingness to share data. Actual sharing was not similarly associated, and none of these estimates establishes a causal effect.
Connected-Fitness Revenue and Business Trends
Peloton’s fiscal 2024 filing provides a concrete view of one connected-fitness company, not a market-size estimate. The fiscal year ended June 30, 2024.
| Peloton fiscal 2024 measure | Amount or rate |
|---|---|
| Connected Fitness Products revenue | $991.7 million |
| Subscription revenue | $1,708.7 million |
| Total revenue | $2,700.5 million |
| Connected Fitness Products share of revenue | 36.7% |
| Subscription share of revenue | 63.3% |
Source: Peloton Interactive, Inc. Form 10-K for fiscal year ended June 30, 2024. The figures are company-reported consolidated and segment accounting measures.
Connected Fitness Products revenue fell 12.2% year over year in fiscal 2024, while Subscription revenue grew 2.3%. The contrasting changes show why hardware revenue, subscription revenue and total fitness-technology activity should not be treated as one metric.
Peloton reported Connected Fitness Products gross margin of 4.9% in fiscal 2024, compared with negative 17.6% in fiscal 2023. Subscription gross margin was 67.8% in fiscal 2024; these are segment accounting measures, not product-level profitability for every brand.
Peloton’s fiscal 2024 sales and marketing expense was $658.9 million, and research and development expense was $304.8 million. These are company expenses, not measures of consumer spending or total industry investment.
Fitness Technology Trials: Steps and Physical Activity
Trial results show what particular interventions did in particular samples, rather than what every tracker or app will achieve. The Fitbit trial involved overweight and obese adults and compared Fitbit-only use with SMS prompts plus Fitbit.
After one week, SMS prompts plus Fitbit increased steps by 1,266 per day, while the Fitbit-only arm changed by 48 fewer steps per day. Moderate-to-vigorous physical activity increased by 17.8 minutes per week in the SMS-plus-Fitbit arm versus 2.3 minutes in the Fitbit-only arm.
Total active time increased by 38.3 minutes per week after one week with SMS prompts plus Fitbit, compared with a 6.7-minute decrease in the comparison arm. At six weeks, however, ActiGraph steps changed by 24 per day in the SMS-plus-Fitbit arm versus a 433-step decrease in Fitbit-only participants, and the reported between-arm difference was not statistically significant.
At six weeks, ActiGraph moderate-to-vigorous physical activity changed by −1.1 minutes per week in the SMS-plus-Fitbit arm versus +4.3 minutes in Fitbit-only participants. These short-term and six-week findings come from a small randomized study with self-selected participants.
A separate 12-month randomized wearable-ring study reported intervention-group mean steps rising from 7,446 per day at baseline to 9,626 by month 3. At month 3, the intervention averaged 9,626 steps per day versus 7,527 in controls.
Long-term guided feedback averaged 10,126 steps per day at month 6 and 11,920 at month 12. At month 9, it averaged 11,171 steps per day versus 9,581 for short-term guided feedback, and at month 12 it averaged 11,920 versus 9,527 in controls.
Sources: Fitbit and SMS randomized controlled trial and 12-month wearable biometric ring study. These are study-specific trial estimates with different populations, interventions and follow-up periods.
Fitness Technology Trials: Sedentary Time and Cardiometabolic Outcomes
A 12-week randomized controlled trial studied sedentary adults using a consumer wearable activity tracker. Compared with control, the intervention reduced sedentary behavior by 81 minutes per day, with a confidence interval from −151 to −12 minutes per day.
| Outcome versus control | Between-group change |
|---|---|
| Steps | +3,117 per day |
| Standing time | +62 minutes per day |
| Light-intensity activity | +28 minutes per day |
| Moderate-to-vigorous activity | +22 minutes per day |
| Body-fat mass | −1.67 kg |
| Body-fat percentage | −1.5 percentage points |
Source: A 12-week consumer wearable activity tracker-based intervention. Confidence intervals were 827–5,406 steps per day, 14–110 standing minutes per day, 5–50 light-activity minutes per day, 4–40 moderate-to-vigorous-activity minutes per day, −3.21 to −0.14 kg and −2.9 to −0.1 percentage points, respectively.
The same trial reported a triglyceride reduction of 0.31 mmol/L versus control, a two-hour insulin reduction of 181 pmol/L and a quantitative insulin-sensitivity check index reduction of 0.022. Their confidence intervals were −0.62 to −0.01 mmol/L, −409 to −46 pmol/L and −0.043 to −0.008, respectively.
These cardiometabolic findings are outcomes from one 12-week randomized trial among sedentary adults. They should not be generalized to every device, program or population.
Fitness App and Wearable Adherence Over Time
Adherence and feedback intensity can change the pattern of results. In the Step4Life pilot randomized trial among hemodialysis patients, structured feedback produced a 920-step daily increase at 12 weeks, compared with 281 steps with tracker-only use.
The between-group difference in Step4Life was 639 steps per day at 12 weeks, with a reported standard deviation of 538 steps. This is a pilot estimate from a specialized clinical population, not a general-adult benchmark.
A pedometer-based web intervention studied adults below 10,000 steps per day at baseline. At baseline, 0% of the at-risk sample met 10,000 steps per day; at the first follow-up, 30% of the intervention arm met the threshold, compared with 11% of controls.
At the second follow-up, 34% of the intervention arm met 10,000 steps per day, compared with 28% of controls. The intervention had a significant step-count effect from baseline to the first follow-up, F=11.98 and P=.001, and from baseline to the second follow-up, F=5.54 and P=.02.
Sources: Step4Life pilot randomized controlled trial and web-based pedometer intervention trial. The 10,000-step results are trial-specific outcomes, and the intervention sample was defined by baseline step behavior.